$BMY U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag™ (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma otcdynamics.com/bmy-u-s-foo...
Relatlimab
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.8¢ |
Change
-0.018(5.07%) |
Mkt cap ! $479.3M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.5¢ | $726.8K | 2.184M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 214552 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 189533 | 33 |
View Market Depth
| Last trade - 15.11pm 27/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |